- Home
- Our Capabilities
- Research & Development
Comprehensive R&D Expertise for Faster Market Access
Partner with Teyro to accelerate drug development, optimize formulations, and bring technology-oriented, high-quality pharmaceutical products to global markets efficiently and effectively.
- Home
- Our Capabilities
- Research & Development
Comprehensive R&D Expertise for Faster Market Access
Partner with Teyro to accelerate drug development, optimize formulations, and bring technology-oriented, high-quality pharmaceutical products to global markets efficiently and effectively.
We would like to be known not only for product development & manufacturing in the generic space, but also as a creator of differentiated product technologies for quick access to the market for our partners.
In the current global R&D scenario where the emphasis is on increasing need to maximize the value of existing active ingredients. we would like to explore development of New Formulations, Line Extensions, Modified Release, Reduced Strength, Reduced Frequency, Combinations, and Alternate Routes of Administration for approved products or unapproved grandfathered products under consideration of 505 (b)(2) submissions.
In our quest for incremental innovation to add value or meet unmet medical need, we would continuously look for opportunities to change or improve the existing drug products and delivery systems. Our competency and strong knowledge base in the area of dosage design would be of great help to our partners looking for customized delivery systems.
Our Research & Development Capabilities & Infrastructure
Teyro Lab’s Research & Development facility is fully equipped to facilitate quality and efficient research & development work.
Expertise in developing and filing F2F, 505(b)2, P-IV, Non-infringing formulations.
Expertise to synthesize solutions for complex problems with quick turnaround time & cost effectiveness
Strong capabilities for Potent and Complex Generic formulations
Combined expertise in POC-stage drug development of various formulations and 100+ ANDAs approval for various products including tablets, capsules, and injectable formulations (liquid & lyophilized)
Teyro’s decades of Hands-on experience in formulation development, technology transfer of various dosage forms gives Teyro a unique confidence of seamlessly transferring the technology to the manufacturing sites of customers across the globe.
Teyro brings capabilities with latest development in the international regulatory environment.
Proven track record in executing SB & EB for tablets, capsules, and injectables for top-tier MNC partners and international customers in USA, Europe, and Asia
Expertise in seamless scale-up and technology transfer
Pilot cGMP High Potent Manufacturing Capabilities
Dedicated Pilot cGMP manufacturing facility for producing tablets, capsules, and injectables (liquid & lyophilized) for Oncology, Hormones and High Potent products with Isolator and RABS technology to handle OEB-5 level products for clinical/investigational purposes.
The Pilot GMP compliant injection facility has capacity to handle 10 to 50 Liters of sterile bulk solution, with filling speed of 1800 vials per hour and Lyophilization upto 5500 vials.
The pilot GMP compliant OSD facility is equipped with integrated granulation line with compression and coating facility for tablets and capsules filling.
Our Commitment to Product Launch and Faster Access to Patients
Most CDMOs focus on execution but Teyro innovates. We combine R&D expertise with cutting-edge analytics, and agile development models to reduce time-to-market while ensuring cost efficiency and regulatory compliance.
Designed and operated to meet regulatory standards
Expertly Formulated.
Rapidly Delivered.
Gain efficiency and confidence with Teyro Labs’ advanced
technology transfer and regulatory expertise. Get started now.
